
NeuroGenesis Announces Positive Phase 2 Extension Study Results of NG01 Cell Therapy in Progressive Multiple Sclerosis
Study shows NG01 improved mobility, cognition, and quality of life, marking a step forward in treatment for progressive multiple sclerosis. ROCHESTER, NY, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- NeuroGenesis today announced new …